Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Free Cash Flow (2016 - 2025)

Veracyte (VCYT) has disclosed Free Cash Flow for 14 consecutive years, with $56.2 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow rose 307.37% to $56.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $134.0 million through Dec 2025, up 110.0% year-over-year, with the annual reading at $134.0 million for FY2025, 110.0% up from the prior year.
  • Free Cash Flow hit $56.2 million in Q4 2025 for Veracyte, up from $39.4 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $56.2 million in Q4 2025 to a low of -$40.9 million in Q1 2021.
  • Historically, Free Cash Flow has averaged $10.1 million across 5 years, with a median of $7.3 million in 2021.
  • Biggest five-year swings in Free Cash Flow: plummeted 585.85% in 2021 and later soared 20305.56% in 2023.
  • Year by year, Free Cash Flow stood at $7.6 million in 2021, then grew by 28.32% to $9.8 million in 2022, then soared by 33.77% to $13.1 million in 2023, then increased by 5.62% to $13.8 million in 2024, then surged by 307.37% to $56.2 million in 2025.
  • Business Quant data shows Free Cash Flow for VCYT at $56.2 million in Q4 2025, $39.4 million in Q3 2025, and $34.1 million in Q2 2025.